BCL2 inhibitor VOB560
Term · Oncology and biomedicine · MLC-T-ONC-011906
An inhibitor of the anti-apoptotic protein B-cell lymphoma 2 (Bcl-2), with potential pro-apoptotic and antineoplastic activities. Upon intravenous administration, Bcl-2 inhibitor VOB560 binds to and inhibits the activity of Bcl-2, thereby restoring apoptotic processes in tumor cells. Bcl-2 protein is overexpressed in many cancer types and plays an important role in the negative regulation of apoptosis; its expression is associated with increased drug resistance and tumor cell survival.
| Identifier | MLC-T-ONC-011906 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | Bcl-2 inhibitor S65487 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-011906",
"term": "BCL2 inhibitor VOB560",
"field": "Oncology and biomedicine",
"definition": "An inhibitor of the anti-apoptotic protein B-cell lymphoma 2 (Bcl-2), with potential pro-apoptotic and antineoplastic activities. Upon intravenous administration, Bcl-2 inhibitor VOB560 binds to and inhibits the activity of Bcl-2, thereby restoring apoptotic processes in tumor cells. Bcl-2 protein is overexpressed in many cancer types and plays an important role in the negative regulation of apoptosis; its expression is associated with increased drug resistance and tumor cell survival.",
"synonyms": [
"Bcl-2 inhibitor S65487"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/bcl2-inhibitor-vob560/"
}
Record 3,350 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.